glp-1 blindness Lawsuits claiming Ozempic, other GLP-1s led to become second mass litigation over the drugs GLP-1 Receptor Agonists and Sight-Threatening
Description
Additionally, patients with active severe gallbladder disease or bile duct obstruction must avoid GLP-1 medications until their condition resolves completely
Sitagliptin: a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Eight percent report using GLP-1s to manage an addiction such as alcohol or opioids
p 7.5% or 58.5 mmol/mol (monotherapy)
doi: 10.1111/j.1399-3011.1992.tb00309.x
Check out this excellent editorial from Dr
